Herrero-Fresneda I - Search Results

1

Different renal toxicity profiles in the association of cyclosporine and tacrolimus with sirolimus in rats.

Lloberas N, Torras J, Alperovich G, Cruzado JM, Giménez-Bonafé P, Herrero-Fresneda I, Franquesa Ml, Rama I, Grinyó JM. Lloberas N, et al. Nephrol Dial Transplant. 2008 Oct;23(10):3111-9. doi: 10.1093/ndt/gfn223. Epub 2008 May 9. Nephrol Dial Transplant. 2008. PMID: 18469305

2

Reduction of postischemic immune inflammatory response: an effective strategy for attenuating chronic allograft nephropathy.

Herrero-Fresneda I, Torras J, Vidal A, Lloberas N, Cruzado JM, Grinyó JM. Herrero-Fresneda I, et al. Transplantation. 2005 Jan 27;79(2):165-73. doi: 10.1097/01.tp.0000147198.88801.57. Transplantation. 2005. PMID: 15665764

3

Rapamycin has dual opposing effects on proteinuric experimental nephropathies: is it a matter of podocyte damage?

Torras J, Herrero-Fresneda I, Gulias O, Flaquer M, Vidal A, Cruzado JM, Lloberas N, Franquesa Ml, Grinyó JM. Torras J, et al. Nephrol Dial Transplant. 2009 Dec;24(12):3632-40. doi: 10.1093/ndt/gfp367. Epub 2009 Aug 11. Nephrol Dial Transplant. 2009. PMID: 19671594

4

The combination of sirolimus and rosiglitazone produces a renoprotective effect on diabetic kidney disease in rats.

Flaquer M, Lloberas N, Franquesa M, Torras J, Vidal A, Rosa JL, Herrero-Fresneda I, Grinyó JM, Cruzado JM. Flaquer M, et al. Life Sci. 2010 Jul 31;87(5-6):147-53. doi: 10.1016/j.lfs.2010.06.004. Epub 2010 Jun 18. Life Sci. 2010. PMID: 20600147

5

Impact of small molecules immunosuppressants on P-glycoprotein activity and T-cell function.

Llaudó I, Cassis L, Torras J, Bestard O, Franquesa Ml, Cruzado JM, Cerezo G, Castaño E, Pétriz J, Herrero-Fresneda I, Grinyó JM, Lloberas N. Llaudó I, et al. Among authors: herrero fresneda i. J Pharm Pharm Sci. 2012;15(3):407-19. doi: 10.18433/j3g30b. J Pharm Pharm Sci. 2012. PMID: 22974789 Free article.

6

Do alloreactivity and prolonged cold ischemia cause different elementary lesions in chronic allograft nephropathy?

Herrero-Fresneda I, Torras J, Cruzado JM, Condom E, Vidal A, Riera M, Lloberas N, Alsina J, Grinyo JM. Herrero-Fresneda I, et al. Am J Pathol. 2003 Jan;162(1):127-37. doi: 10.1016/S0002-9440(10)63804-7. Am J Pathol. 2003. PMID: 12507896 Free PMC article.

7

Regression of advanced diabetic nephropathy by hepatocyte growth factor gene therapy in rats.

Cruzado JM, Lloberas N, Torras J, Riera M, Fillat C, Herrero-Fresneda I, Aran JM, Alperovich G, Vidal A, Grinyó JM. Cruzado JM, et al. Diabetes. 2004 Apr;53(4):1119-27. doi: 10.2337/diabetes.53.4.1119. Diabetes. 2004. PMID: 15047630 Free article.

8

Mammalian target of rapamycin pathway blockade slows progression of diabetic kidney disease in rats.

Lloberas N, Cruzado JM, Franquesa M, Herrero-Fresneda I, Torras J, Alperovich G, Rama I, Vidal A, Grinyó JM. Lloberas N, et al. J Am Soc Nephrol. 2006 May;17(5):1395-404. doi: 10.1681/ASN.2005050549. Epub 2006 Apr 5. J Am Soc Nephrol. 2006. PMID: 16597691

9

Gene therapy for acute renal failure.

Torras J, Cruzado JM, Herrero-Fresneda I, Grinyo JM. Torras J, et al. Contrib Nephrol. 2008;159:96-108. doi: 10.1159/000125614. Contrib Nephrol. 2008. PMID: 18391587 Review.

10

Different storing and processing conditions of human lymphocytes do not alter P-glycoprotein rhodamine 123 efflux.

Chiva-Blanch G, Giménez-Bonafe P, Llaudó I, Torras J, Cruzado JM, Petriz J, Castaño E, Franquesa Ml, Herrero-Fresneda I, Tortosa A, Rama I, Bestard O, Grinyó JM, Lloberas N. Chiva-Blanch G, et al. J Pharm Pharm Sci. 2009;12(3):357-66. doi: 10.18433/j34g69. J Pharm Pharm Sci. 2009. PMID: 20067710 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38 results

Search Page

Filters